Strategic Resource Management
策略性資源管理

強化研發 (R&D) 之生產力、預測性和規劃性所需的工具和策略

2024年10月9~10日(EDT)

由於藥物開發時間線的高低起伏,生物醫藥研發在資源管理、預測和容量規劃方面面臨巨大挑戰。為了管理延遲和產品缺陷的固有風險,企業需要開發有效的績效計劃、創收合作關係和數據管理功能,並創建和維持符合項目組合優先排序的靈活資源管理系統和流程。本次會議將邀集生物醫藥行業的資深戰略和管理領導者,以管理資源和能力以及提高研發 (R&D) 生產力為目標,探索新方法並分享最佳實踐。

10月9日 星期三

Registration Open12:00 pm

1:00 pm

Chairperson's Remarks

Peter Ray, Vice President, Head of Portfolio Analytics, Novartis

1:10 pm KEYNOTE PRESENTATION:

Unlock the Power of Change: Elevate Your Leadership Journey

Mary Lou Panzano, Founder and CEO, Panzano Enterprises LLC; Former Vice President, Internal Communications, Bayer

Michelle Shogren, CEO & Owner, Innovate in What You Do!; former Senior Director of Innovation, Pharma R&D Clinical Operations, Bayer

As a forward-thinking leader, you wield the power to orchestrate transformative change within your organization. Yet, amidst the dynamic landscape of progress, do you possess the essential toolkit to navigate inevitable challenges and conflicts, ensuring collaboration prevails over escalation? Join us for an engaging session where you'll uncover not only the five critical pillars of effective change management but also strategies for adept conflict resolution. Gain invaluable insights to steer your organization towards a future of innovation, resilience, and sustainable growth. Seize this transformative opportunity to elevate your leadership prowess and drive impactful change.

1:50 pm KEYNOTE PRESENTATION:

Employing AI to Increase R&D Productivity

Helen Merianos, PhD, Head, R&D Portfolio Strategy, Sanofi

Sanofi, a pharmaceutical company of 100,000+ employees that develops medicines and vaccines, began a business transformation in portfolio management, leveraging artificial intelligence (AI) as a key accelerator. As part of our business transformation, we've co-developed a decision intelligence tool called PLai that correlates >1B data points in a single source of truth, and leverages AI to make recommendations from strategy to operations.  We use AI predictions to challenge our internal view on key parameters. 

Refreshment Break with Exhibit Viewing2:30 pm

BREAKOUT DISSCUSSIONS

3:00 pmBreakout Discussions

Breakout Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing. Please visit the Breakout Discussions page on the conference website for a complete listing of topics and descriptions.

Sponsored Presentation (Opportunity Available)4:00 pm

4:30 pm PANEL DISCUSSION

Simplifying Portfolio and Resource Management Processes in the Age of Analytics

PANEL MODERATOR:

Michael Myers, PhD, Associate Vice President, LRL Project Management-Due Diligence, Eli Lilly and Company

There has been an increased emphasis in leveraging advanced analytics across the scientific and business worlds. Sometimes our desire to test the latest tools and algorithms may overly complicate our approach or even the ability to make decisions based on the data we are collecting. Advanced analytics techniques, when applied effectively, can be leveraged to better evaluate and prioritize projects based on strategic objectives, risk factors, and resource constraints. Join this panel to discuss the changing analytics landscape, and explore best practices and lessons learned in deploying and leveraging analytics tools in prioritizing projects and resources.

PANELISTS:

Melquiades de Jesus, Senior Director, R&D PMO Business Capabilities, Jazz Pharmaceuticals

Leslie Lippard, Senior Director, Portfolio Analytics, Alnylam Pharmaceuticals

Helen Merianos, PhD, Head, R&D Portfolio Strategy, Sanofi

Peter Ray, Vice President, Head of Portfolio Analytics, Novartis

Close of Day5:15 pm

10月10日 星期四

Registration and Morning Coffee8:00 am

8:25 am

Chairperson's Remarks

Sean Gallagher, Director, Capacity Management and Business Analytics, Johnson & Johnson

8:30 am

Linking Portfolio Intent to Resource Deployment: Best Practices to Enhance Operational Efficiency and Effectiveness

Michael Ferrante, Executive Director, Business Analytics, Global Regulatory Affairs & Clinical Safety, Merck

Effective resource allocation is crucial for achieving organizational goals and optimizing project success. This presentation explores the strategic alignment of portfolio intent with resource allocation, emphasizing the importance of ensuring coherence between company objectives and resource distribution. By leveraging data analysis and forecasting techniques, organizations can make informed decisions to balance resource demand and capacity, thereby enhancing operational efficiency and effectiveness. Case studies and real-world examples will illustrate the positive impact of linking portfolio intent to resource deployment, showcasing how this alignment fosters project success and drives overall business growth.

9:00 am

Implementation of Resource/Capacity Management through Integration with Portfolio Management

Stuart Fort, Senior Director, Project Management Strategy and Capabilities, Eli Lilly and Company

Common challenges in capacity management systems involve maintaining real-time demand data while also dealing with the differing structures and needs of each function in the R&D value chain. This presentation highlights a solution that leverages an existing project and portfolio management system and layers in the resource structure in a flexible and sustainable manner, and putting real-time resource and capacity management analyses in the hands of each functional leader.

Sponsored Presentation (Opportunity Available)9:30 am

Networking Coffee Break10:00 am

10:20 am

Expanded Use of AI and Data Science in Resource Forecasting and Planning

Thomas De Vis, Associate Director Capacity Management, Johnson & Johnson

Sean Gallagher, Director, Capacity Management and Business Analytics, Johnson & Johnson

Embark on a journey into the future of resource forecasting and planning in pharmaceuticals and biotech with Thomas De Vis. Discover how AI and data science are revolutionizing decision-making processes and optimizing resource allocation for enhanced efficiency. Gain actionable insights into leveraging advanced analytics for strategic resource management. Join us for an engaging exploration, featuring a compelling case study from Johnson & Johnson. Don't miss this opportunity to unlock the full potential of AI-driven resource optimization in your organization.

10:50 am

Opportunities to Drive Value: Implementing Fit-for-Purpose Resource Forecasting Capabilities in a Dynamic Environment

Chris Kaster, Director CDO Portfolio Analytics & Governance, CDO Portfolio Analytics & Governance, Moderna Inc.

11:20 am

Firm Boundaries and Incentives: Evidence from the Biopharmaceutical Industry

Christopher Larson, Director Portfolio Program Management, AbbVie

It is well-documented that in-licensed drug projects have higher likelihood of approval than projects developed internally in the biopharmaceutical industry. Using a granular dataset, we show that this result holds when controlling for possible sources of heterogeneity across drug projects. Next, we posit and show that the success rate difference is partly driven by agency problems within companies. Namely, internal R&D teams may bring forward less promising drug projects due to monetary and career incentives. We also show that this mechanism is distinct and coexists with selection effects and contractual inflexibility mechanisms proposed in previous literature.

Networking Luncheon11:50 am

12:50 pm

Chairperson's Remarks

Alexander Rucci, Director, Project Management, Sumitomo Pharma America

12:55 pm

Increasing Employee Efficiency Post-Portfolio Re-Prioritization and Company Transformation

Alexander Rucci, Director, Project Management, Sumitomo Pharma America

In early 2024 SMPA announced a major organizational restructuring including, a rationalization of workforce along with major changes to our biggest partnership. The Global Corporate Strategy team needed to develop new processes that track key strategic metrics across the finance, resource, and milestones spaces. This presentation will show our team's approach to this opportunity, along with a strategy to implement results.

1:25 pm

Optimizing Resource Allocation-Approaches for Internal, External, and Regional Sourcing

Sabine Lenders, Associate Director, Capacity Management, Johnson & Johnson Innovative Medicine

This session will delve into strategies to maximize organizational efficiency through internal collaboration, strategic external partnerships, and regional considerations. Discover insights, case studies, and decision frameworks essential for executives navigating complex resource allocation challenges. Join us to unlock the potential of your resource management endeavors.

Presentation to be Announced1:55 pm

2:25 pm

Closing Remarks

Alexander Rucci, Director, Project Management, Sumitomo Pharma America

Close of Strategic Resource Management Conference2:30 pm

* 活動內容有可能不事先告知作更動及調整

Choose your language
Chinese
Japanese
Korean
English


Program and Portfolio Management